The company is located at Centre for Molecular Medicine at Karolinska Institutet, Stockholm, Sweden. NEOGAP Therapeutics strives to increase overall survival among patients with cancer by boosting tumour-specific responses of the immune system.
NEOGAP Therapeutics
NEOGAP Therapeutics is a privately held biopharmaceutical company with the main focus on immuno-oncology.
